Our understanding of the natural history of renal cell carcinoma and the possibilities of new technologies are evolving and being integrated with advances in classification and staging. In this article we reviewed the literature in order to provide an analysis of the changing epidemiology of renal cell carcinoma.
Radiological evaluation of renal masses has rapidly progressed from conventional angiography and intravenous urography to ultrasounds, CT and MRI. As more patients are imaged for many opportunities, the incidental detection has increased. This article reviews the imaging and not techniques in order to characterize these lesions accurately.
PantuckA.J., ZismanA., BelldegrunA.S.. The changing natural history of renal cell carcinoma.J Urol2001; 166: 1611–23.
5.
JemalA., ThomasA., MurrayT.. Cancer statistics, 2002.CA Cancer J Clin2002; 52: 23–47.
6.
WunderlichH., SchumannS., JantizkyV.. Increase of renal cell carcinoma. Incidence in Central Europe.Eur Urol1998; 33: 538–41.
7.
ParkinD.M., MuirC.S., WhelanS.. Cancer incidence in five continents. Vol VI, IARC Scientific Publication n° 120 World Health Organization, International Agency for Research on Cancer, Lyon1992.
8.
MartelC.L., LaraP.N.. Renal cell carcinoma: current status and future directions.Crit Rev Oncol Hematol2003; 45: 177–90.
LinehanW.M., LermanM.I., ZbarB.. Identification of the von Hippel-Lindau (VHL) gene: its role in renal cancer.JAMA1995; 273: 564–70.
13.
CohenA.J., LiF.P., BergS.. Hereditary renal-cell carcinoma associated with a cromosomal translocation.N Engl J Med1979; 301: 592–5.
14.
BelldegrunA., de KernionJ.B.. Renal tumours. In WalshP.C., RetikA.B., VaughanE.D., WeinA.J.W.B. (eds): Campbell's Urology, Philadelphia, Saunders, 1998, 2283–2326.
15.
FilipasD., SpixC., Schulz-LampelD.. Screening for renal cell carcinoma using ultrasonography: A feasibility study.BJU Int2003; 91: 595–9.
16.
MessingE.M., YoungT.B., HuntV.B.. The significance of asymptomatic microhematuria in men 50 or more years old. Findings of a home screening study using urinary dipsticks.J Urol1987; 137: 919–22.
17.
SufrinG., ChasanS., GolioA.. Paraneoplastic and serologic syndromes of renal adenocarcinoma.Semin Urol1989; 7: 158–71.
18.
KimH.L., BelldegrunA., FreitasD.. Paraneoplastic signs and symptoms of renal cell carcinoma: implications for prognosis.J Urol2003; 170: 1742–6.
19.
AmendolaM., BreeR.L., PollackH.M.. Small rental carcinomas: resolving a diagnostic dilemma.Radiology1988, 166: 637.
BechtoldR.E., ZagoriaR.J.. Imaging approach to staging of renal cell carcinoma.Urol Clin North Am1997; 24: 507.
22.
BirnbaumB.A., JacobsJ.E., RamchandaniP.. Multiphasic renal CT: comparison of renal mass enhancement during the corticomedullary and nephrografic phases.Radiology1996; 200: 753–8.
23.
CollD.M., HertsB.R., DavrosW.J.. Preoperative use of 3D volume rendering to demonstrate renal tumours and renal anatomy.Radiographics2000; 20: 431–8.
24.
ShethS., ScatarigeJ.C., HortonK.M.. Current concepts in the diagnosis and management of renal cell carcinoma: role of multidetector CT and three-dimensional CT.Radiographics2001; 21(suppl.): S237–54.
25.
NelsonK.L., GiffordL.M., Lauber-HuberC.. Clinical safety of gadopentetate dimeglumine.Radiology1995; 196: 439–43.
26.
PrinceM.R., ArnoldusC., FrisoliJ.K.. Nephrotoxicity of high dose gadolinium compared with iodinated contrast.J Magn Reson Imaging1996; 1: 162–6.
27.
RofskyN.M., WeinrebJ.C., BosniakM.A.. Renal lesion characterization with gadolinium-enhanced MR imaging: efficacy and safety in patients with renal insufficiency.Radiology1991; 180: 85–9.
